View in EDS HTML Full Text PDF Full Text

Evexomostat (SDX-7320), a methionine aminopeptidase type 2 inhibitor, stimulates weight loss and inhibits obesity-accelerated tumor growth.

Saved in:
Bibliographic Details
Title: Evexomostat (SDX-7320), a methionine aminopeptidase type 2 inhibitor, stimulates weight loss and inhibits obesity-accelerated tumor growth.
Authors: Cornelius P; SynDevRx, Inc., Cambridge, MA, United States., Mayes BA; SynDevRx, Inc., Cambridge, MA, United States., Dannenberg AJ; Emerald Bioventures, New York, NY, United States., Dufour PJ; SynDevRx, Inc., Cambridge, MA, United States., Little S; Neosome Life Sciences, Billerica, MA, United States., Guzior DV; Panome Bio, St. Louis, MO, United States., Petersen JS; SynDevRx, Inc., Cambridge, MA, United States., Shanahan JM; SynDevRx, Inc., Cambridge, MA, United States., Carver BJ; SynDevRx, Inc., Cambridge, MA, United States.
Source: Frontiers in oncology [Front Oncol] 2026 Feb 18; Vol. 16, pp. 1751681. Date of Electronic Publication: 2026 Feb 18 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41789003
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evexomostat (SDX-7320), a methionine aminopeptidase type 2 inhibitor, stimulates weight loss and inhibits obesity-accelerated tumor growth.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cornelius+P%22">Cornelius P</searchLink>; SynDevRx, Inc., Cambridge, MA, United States.<br /><searchLink fieldCode="AU" term="%22Mayes+BA%22">Mayes BA</searchLink>; SynDevRx, Inc., Cambridge, MA, United States.<br /><searchLink fieldCode="AU" term="%22Dannenberg+AJ%22">Dannenberg AJ</searchLink>; Emerald Bioventures, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Dufour+PJ%22">Dufour PJ</searchLink>; SynDevRx, Inc., Cambridge, MA, United States.<br /><searchLink fieldCode="AU" term="%22Little+S%22">Little S</searchLink>; Neosome Life Sciences, Billerica, MA, United States.<br /><searchLink fieldCode="AU" term="%22Guzior+DV%22">Guzior DV</searchLink>; Panome Bio, St. Louis, MO, United States.<br /><searchLink fieldCode="AU" term="%22Petersen+JS%22">Petersen JS</searchLink>; SynDevRx, Inc., Cambridge, MA, United States.<br /><searchLink fieldCode="AU" term="%22Shanahan+JM%22">Shanahan JM</searchLink>; SynDevRx, Inc., Cambridge, MA, United States.<br /><searchLink fieldCode="AU" term="%22Carver+BJ%22">Carver BJ</searchLink>; SynDevRx, Inc., Cambridge, MA, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2026 Feb 18; Vol. 16, pp. 1751681. <i>Date of Electronic Publication: </i>2026 Feb 18 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41789003
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2026.1751681
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1751681
    Titles:
      – TitleFull: Evexomostat (SDX-7320), a methionine aminopeptidase type 2 inhibitor, stimulates weight loss and inhibits obesity-accelerated tumor growth.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cornelius P
      – PersonEntity:
          Name:
            NameFull: Mayes BA
      – PersonEntity:
          Name:
            NameFull: Dannenberg AJ
      – PersonEntity:
          Name:
            NameFull: Dufour PJ
      – PersonEntity:
          Name:
            NameFull: Little S
      – PersonEntity:
          Name:
            NameFull: Guzior DV
      – PersonEntity:
          Name:
            NameFull: Petersen JS
      – PersonEntity:
          Name:
            NameFull: Shanahan JM
      – PersonEntity:
          Name:
            NameFull: Carver BJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 02
              Text: 2026 Feb 18
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1